A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients (0639-112)(COMPLETED)
PHASE2CompletedINTERVENTIONAL
Enrollment
330
Participants
Timeline
Start Date
January 31, 2001
Study Completion Date
May 31, 2003
Conditions
HIV Infections
Interventions
DRUG
MK0639, indinavir sulfate / Duration of Treatment: 48 Weeks
DRUG
Comparator: nelfinavir mesylate / Duration of Treatment: 48 Weeks
All Listed Sponsors
lead
Merck Sharp & Dohme LLC
INDUSTRY
NCT00541463 - A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients (0639-112)(COMPLETED) | Biotech Hunter | Biotech Hunter